{"id":190969,"date":"2026-08-07T13:40:41","date_gmt":"2026-08-07T08:10:41","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=190969"},"modified":"2026-08-07T13:40:41","modified_gmt":"2026-08-07T08:10:41","slug":"akums-drugs-and-pharmaceuticals-ltd-share-price-rise-2026-08-07","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/akums-drugs-and-pharmaceuticals-ltd-share-price-rise-2026-08-07\/","title":{"rendered":"Akums Drugs &#038; Pharmaceuticals Ltd. (AKUMS) Share Price Rises 5.49% Today"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Akums Drugs &#038; Pharmaceuticals Ltd. Share Price Today rose to Rs 698.85, up 5.49%, taking the Healthcare mid-cap company\u2019s market capitalisation to Rs 10,483.23 crore.<\/p>\n<p style=\"margin-top:0!important;\">Akums Drugs &#038; Pharmaceuticals Ltd. Share Price moved to Rs 698.85 on 07 August 2026, rising 5.49% or Rs 36.40 from the previous close of Rs 662.45. With market capitalisation at Rs 10,483.23 crore, the stock stood out in Stock Market Today as a mid-cap Healthcare name that cleared the qualifying bar for a same-day price rise in its market-cap category.<\/p>\n<p>For investors searching Akums Drugs &#038; Pharmaceuticals Ltd. Share Price Today, the verified data confirms a strong single-session move rather than a long-term high event. The stock opened at Rs 684.95, traded between Rs 667.50 and Rs 699.35, and was close to the top of that intraday range at the time of this update. That pattern matters because it shows the day\u2019s gains were largely retained into the afternoon instead of fading back toward the opening level.<\/p>\n<p>Why is the stock trending in Akums Drugs &#038; Pharmaceuticals Ltd. Stock News and Akums Drugs &#038; Pharmaceuticals Ltd. News Today searches? The supplied data confirms the price event, turnover of Rs 1.02 crore on BSE, and combined exchange volume of 3,74,164 shares, but it does not establish a company-specific catalyst. What investors can monitor next is whether the price action holds near the day high, how participation evolves across NSE and BSE, and how the company\u2019s size compares with the broader Healthcare sector benchmark. Univest tracks these market signals in a structured, data-first format so readers can separate verified movement from speculation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Akums_Drugs_Pharmaceuticals_Ltd_AKUMS_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Akums Drugs &amp; Pharmaceuticals Ltd. (AKUMS) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 698.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 662.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 36.4 (+5.49%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 684.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 699.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 667.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume (BSE)<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14,615<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>BSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14,615<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>NSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3,59,549<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Combined NSE + BSE Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3,74,164<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.02 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 10,483.23 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/table>\n<p>Akums Drugs &amp; Pharmaceuticals Ltd. (AKUMS) traded at Rs 698.85. versus the previous close of Rs 662.45, a rise of 5.49%. The stock opened at Rs 684.95, reached Rs 699.35, touched Rs 667.5. Reported volume was 14,615.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Akums_Drugs_Pharmaceuticals_Ltd_AKUMS_Fundamental_Analysis\"><\/span><strong>Akums Drugs &amp; Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 10,483.23 crore<\/td>\n<\/tr>\n<\/table>\n<p>Akums Drugs &#038; Pharmaceuticals Ltd. Share Price is now being evaluated against a market capitalisation of Rs 10,483.23 crore, which firmly places it in the mid-cap bracket in this dataset. Market capitalisation describes company size rather than business quality, but size does affect how investors frame liquidity, benchmarking and peer comparison. In this case, the stock\u2019s market value is meaningfully larger than the broader Healthcare sector sample medians and averages supplied in the benchmark snapshot.<\/p>\n<p>The key fundamental context available in the dataset is comparative rather than company-specific. That matters because investors tracking Akums Drugs &#038; Pharmaceuticals Ltd. Fundamental Analysis should distinguish between what is known about today\u2019s trading event and what the supplied numbers allow on valuation. The stock\u2019s current price of Rs 698.85 after a 5.49% share price gain shows the market has re-rated the stock higher during the session, but the supplied data does not include company-specific P\/E ratio, P\/B ratio, EV\/EBITDA, ROE, ROCE, EPS, book value, dividend yield, leverage or cash flow figures. As a result, the most useful fundamental reading is relative positioning through size, sector snapshot and peer context rather than unsupported balance-sheet interpretation.<\/p>\n<p>That still offers real analytical value. A company with a market capitalisation of Rs 10,483.23 crore sits far above the same-sector benchmark median market cap of Rs 140.58 crore and the benchmark average of Rs 471.12 crore. It is also above the benchmark maximum of Rs 3,060.41 crore in the supplied sector basket. So while Akums Drugs &#038; Pharmaceuticals Ltd. Share Price Today is being discussed for a one-day rise, the company\u2019s scale already stands out versus many listed Healthcare names in this benchmark universe.<\/p>\n<p>For readers looking for Akums Drugs &#038; Pharmaceuticals Ltd. Stock Analysis or Akums Drugs &#038; Pharmaceuticals Ltd. Financial Results context, today\u2019s move is most credibly framed as a price event in a relatively large Healthcare stock within this peer set. Univest views that combination of market-cap scale and same-day strength as a reason to monitor the stock closely, while keeping interpretation strictly tied to verified data. That naturally leads into where the stock sits within its sector and peer landscape.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.27x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">92.32x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.3x to 3,493.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.77%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 10,483.23 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 140.58 crore<\/td>\n<\/tr>\n<\/table>\n<p>Akums Drugs &amp; Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare.<\/p>\n<p>Track today&#8217;s top gainers through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<p>Akums Drugs &#038; Pharmaceuticals Ltd. Share Price is moving within the Healthcare sector, and the strongest benchmark context comes from a same-sector sample of 198 companies. That benchmark shows a wide valuation and profitability spread, which is important when assessing whether today\u2019s price rise is part of a broader sector pattern or a company-specific market move.<\/p>\n<p>Within that 198-company Healthcare benchmark, P\/E data is available for 156 companies. The median P\/E stands at 26.27, the average P\/E at 92.32, with a minimum of 3.30 and a maximum of 3,493.04. For price-to-book, 197 companies are covered, with a median of 1.95, average of 2.55, minimum of -21.27 and maximum of 16.42. Profitability also varies sharply: ROE across 197 companies shows a median of 10.77 and an average of 15.32, while ROCE across 197 companies shows a median of 13.35 and an average of 17.69.<\/p>\n<p>Market capitalisation dispersion is similarly wide. Across 198 companies, the median market cap is Rs 140.58 crore and the average is Rs 471.12 crore, with the range stretching from Rs 4.29 crore to Rs 3,060.41 crore. Against that backdrop, Akums Drugs &#038; Pharmaceuticals Ltd. Share Price represents a company whose market capitalisation of Rs 10,483.23 crore sits well above the benchmark maximum in the supplied sector basket. That does not by itself establish valuation quality, but it does show the stock occupies a much larger size position than most names in this comparison set.<\/p>\n<p>The peer list in the benchmark is dominated by Pharmaceuticals &#038; Drugs companies, with one Hospital &#038; Healthcare Services name also present. For investors reading Akums Drugs &#038; Pharmaceuticals Ltd. Stock News or Akums Drugs &#038; Pharmaceuticals Ltd. Latest News, this sector view suggests that today\u2019s move occurred in a sector where valuation, profitability and company size vary substantially. Univest therefore sees the sector benchmark as a useful filter: the stock is notable not only because it rose today, but because it did so from a market-cap base much larger than the benchmark sample\u2019s central tendency.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,060.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.46<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\"><strong>Hikal Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HIKAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,862.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,652.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">40.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,623.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">67.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/panaceabio\/panacea-biotec-ltd-share-price-today\"><strong>Panacea Biotec Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">PANACEABIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,571.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.36<\/td>\n<\/tr>\n<\/table>\n<p>Akums Drugs &amp; Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 10,483.23 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<p>Akums Drugs &#038; Pharmaceuticals Ltd. Share Price can also be understood by comparing the company\u2019s scale with selected listed peers from the supplied Healthcare snapshot. Even without full company-specific valuation ratios in the dataset, relative market-cap positioning is highly visible. At Rs 10,483.23 crore, Akums Drugs &#038; Pharmaceuticals Ltd. is larger than Dishman Carbogen Amcis Ltd. at Rs 3,060.41 crore, Hikal Ltd. at Rs 2,862.43 crore, Kwality Pharmaceuticals Ltd. at Rs 2,652.52 crore, Beta Drugs Ltd. at Rs 2,623.92 crore and Panacea Biotec Ltd. at Rs 2,571.92 crore. It also exceeds Dr Agarwals Eye Hospital Ltd. at Rs 2,537.31 crore, Solara Active Pharma Sciences Ltd. at Rs 2,481.41 crore, Sai Parenteral&#8217;s Ltd. at Rs 2,290.47 crore, Fredun Pharmaceuticals Ltd. at Rs 2,171.94 crore and NGL Fine-Chem Ltd. at Rs 2,127.68 crore.<\/p>\n<p>The supplied peer ratios underline how diverse the Healthcare space is. Dishman Carbogen Amcis shows a P\/E of 31.30, P\/B of 0.46, ROE of -2.89 and ROCE of -0.26. Kwality Pharmaceuticals carries a P\/E of 40.87, P\/B of 8.32, ROE of 28.21 and ROCE of 26.35. Beta Drugs trades at a P\/E of 67.31 and P\/B of 10.65, with ROE of 18.65 and ROCE of 22.17. Sai Parenteral&#8217;s posts a P\/E of 167.74, P\/B of 3.10, ROE of 13.90 and ROCE of 12.97. NGL Fine-Chem shows a P\/E of 44.10, P\/B of 6.45, ROE of 27.90 and ROCE of 33.91.<\/p>\n<p>Hikal, Panacea Biotec and Solara Active Pharma Sciences do not all have complete P\/E fields in the supplied peer data, but their profitability figures still show variation. Hikal reports ROE of 15.22 and ROCE of 16.15, Panacea Biotec shows ROE of 0 and ROCE of 5.36, while Solara reports ROE of 17.23 and ROCE of 15.34. Dr Agarwals Eye Hospital has a P\/E of 33.29, P\/B of 6.86, ROE of -2.60 and ROCE of 16.92. Fredun Pharmaceuticals carries a P\/E of 46.11, P\/B of 6.89, ROE of 11.42 and ROCE of 13.15.<\/p>\n<p>For Akums Drugs &#038; Pharmaceuticals Ltd. Share Price News, the main peer takeaway is straightforward: the company is being watched today not because it is small and thinly valued within this set, but because it is substantially larger than every supplied peer by market capitalisation. Univest considers that an important context marker when a stock appears among market movers.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Akums_Drugs_Pharmaceuticals_Ltd\"><\/span><strong>Why Investors Are Watching Akums Drugs &#038; Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Akums Drugs &#038; Pharmaceuticals Ltd. Share Price is being watched because today\u2019s move combines a meaningful one-day gain, strong intraday retention and an unusually large market-cap position relative to the supplied Healthcare benchmark. In a market session where investors scan Stocks in News and Market Movers, these verified signals are enough to keep the stock on active watchlists.<\/p>\n<ul>\n<li><strong>Verified price action:<\/strong> the stock rose Rs 36.40, or 5.49%, from Rs 662.45 to Rs 698.85.<\/li>\n<li><strong>Intraday behaviour:<\/strong> it traded between Rs 667.50 and Rs 699.35 and remained close to the day high.<\/li>\n<li><strong>Volume footprint:<\/strong> total traded volume reached 3,74,164 shares, including 3,59,549 on NSE and 14,615 on BSE.<\/li>\n<li><strong>Turnover context:<\/strong> BSE turnover was Rs 1.02 crore.<\/li>\n<li><strong>Market-cap relevance:<\/strong> Rs 10,483.23 crore places it well above the supplied sector benchmark range.<\/li>\n<li><strong>Sector context:<\/strong> the stock sits within Healthcare, a benchmark universe of 198 companies with wide valuation dispersion.<\/li>\n<\/ul>\n<p>What should investors monitor next? The most practical checkpoints are whether Akums Drugs &#038; Pharmaceuticals Ltd. Share Price continues to hold near the upper end of today\u2019s Rs 667.50 to Rs 699.35 range, whether volume remains broad across exchanges, and whether the stock keeps standing out versus sector and peer benchmarks. Univest also recommends tracking future market updates in the same fact-led way, focusing on price, liquidity and relative positioning rather than unverified narratives.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Akums_Drugs_Pharmaceuticals_Ltd\"><\/span><strong>About Akums Drugs &#038; Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>In the supplied market dataset, Akums Drugs &#038; Pharmaceuticals Ltd. is identified as a listed Healthcare company. That is the most direct verified business classification available for this article, and it places the stock inside a sector where listed companies span pharmaceuticals, drugs and healthcare services within the benchmark snapshot.<\/p>\n<p>From an equity-market perspective, Akums Drugs &#038; Pharmaceuticals Ltd. Share Price is currently being assessed as a mid-cap Healthcare stock with a market capitalisation of Rs 10,483.23 crore. That makes the company materially larger than the median and average company sizes in the same-sector benchmark, and even above the maximum market-cap value shown in the supplied comparison basket. In practical terms, that can influence how the stock appears on screener lists, sector rankings and market-cap based scans.<\/p>\n<p>The broader benchmark mix also suggests that investors often compare Healthcare names not just by price movement, but by valuation ratios, profitability and scale. While this article avoids unsupported business-detail claims, the available data still places Akums Drugs &#038; Pharmaceuticals Ltd. within an actively tracked corner of the Indian stock market where peer comparisons frequently include Pharmaceuticals &#038; Drugs companies such as Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs, Solara Active Pharma Sciences and NGL Fine-Chem. For readers following Akums Drugs &#038; Pharmaceuticals Ltd. Company News, that context helps explain why a one-day share price rise can quickly bring the stock into broader sector focus.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Akums_Drugs_Pharmaceuticals_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Akums Drugs &#038; Pharmaceuticals Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/akums\/akums-drugs-and-pharmaceuticals-ltd-share-price-today\">Akums Drugs &amp; Pharmaceuticals Ltd. (AKUMS) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top gainers lists and related market analysis.<\/p>\n<p>Investors who want to follow Akums Drugs &#038; Pharmaceuticals Ltd. Share Price more closely can use Univest to track live share price movement, market capitalisation, 52-week levels, shareholding pattern updates when available, and key market insights in one place. Univest also helps users compare listed stocks through sector benchmarks, peer sets and event-based tracking such as top gainers and other stock updates.<\/p>\n<p>For Akums Drugs &#038; Pharmaceuticals Ltd. Share Price Today, the most relevant tools are live price monitoring, exchange-wise volume checks, market-cap context and structured stock analysis based only on verified numbers. As Akums Drugs &#038; Pharmaceuticals Ltd. Stock News evolves, Univest keeps the focus on measurable data points rather than speculation, helping readers monitor the stock with a disciplined market framework.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Akums_Drugs_Pharmaceuticals_Ltd_Share_Price_today\"><\/span><strong>What is the Akums Drugs &amp; Pharmaceuticals Ltd. Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Akums Drugs &amp; Pharmaceuticals Ltd. Share Price today was Rs 698.85 at the time of this update. The stock was up Rs 36.40, or 5.49%, from the previous close of Rs 662.45 on 07 August 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Akums_Drugs_Pharmaceuticals_Ltd_rising_today\"><\/span><strong>Why is Akums Drugs &amp; Pharmaceuticals Ltd. rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that Akums Drugs &amp; Pharmaceuticals Ltd. rose 5.49% today and cleared the qualifying price-rise bar for its Mid Cap category. The dataset confirms the move and volumes, but it does not establish a company-specific catalyst.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_the_day_high_and_day_low_for_Akums_Drugs_Pharmaceuticals_Ltd\"><\/span><strong>What were the day high and day low for Akums Drugs &amp; Pharmaceuticals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Akums Drugs &amp; Pharmaceuticals Ltd. traded between a day low of Rs 667.50 and a day high of Rs 699.35. The current price of Rs 698.85 was close to the upper end of that intraday range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Akums_Drugs_Pharmaceuticals_Ltd_gain_compared_with_the_previous_close\"><\/span><strong>How much did Akums Drugs &amp; Pharmaceuticals Ltd. gain compared with the previous close?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Akums Drugs &amp; Pharmaceuticals Ltd. gained Rs 36.40 over the previous close of Rs 662.45. In percentage terms, the stock rose 5.49%, making it one of the more closely watched price rises in today\u2019s market session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_opening_price_of_Akums_Drugs_Pharmaceuticals_Ltd_today\"><\/span><strong>What was the opening price of Akums Drugs &amp; Pharmaceuticals Ltd. today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Akums Drugs &amp; Pharmaceuticals Ltd. opened at Rs 684.95 today. That opening level was above the previous close of Rs 662.45, and the stock later extended gains to an intraday high of Rs 699.35.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Akums_Drugs_Pharmaceuticals_Ltd\"><\/span><strong>What is the market capitalisation of Akums Drugs &amp; Pharmaceuticals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Akums Drugs &amp; Pharmaceuticals Ltd. had a market capitalisation of Rs 10,483.23 crore in the supplied data. That places the company in the Mid Cap category and well above the same-sector benchmark median of Rs 140.58 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_volume_was_traded_in_Akums_Drugs_Pharmaceuticals_Ltd_shares_today\"><\/span><strong>How much volume was traded in Akums Drugs &amp; Pharmaceuticals Ltd. shares today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Total traded volume in Akums Drugs &amp; Pharmaceuticals Ltd. shares was 3,74,164. That included 3,59,549 shares on NSE and 14,615 shares on BSE, showing that most of today\u2019s trading activity was concentrated on NSE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_BSE_turnover_in_Akums_Drugs_Pharmaceuticals_Ltd_today\"><\/span><strong>What was the BSE turnover in Akums Drugs &amp; Pharmaceuticals Ltd. today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied BSE turnover for Akums Drugs &amp; Pharmaceuticals Ltd. was Rs 1.02 crore today. Alongside BSE volume of 14,615 shares, this provides useful context for the stock\u2019s exchange-level trading activity during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_sector_does_Akums_Drugs_Pharmaceuticals_Ltd_belong_to\"><\/span><strong>Which sector does Akums Drugs &amp; Pharmaceuticals Ltd. belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Akums Drugs &amp; Pharmaceuticals Ltd. is classified under the Healthcare sector in the supplied dataset. The same-sector benchmark covers 198 companies, giving investors a broad comparative frame for market cap and sector-level valuation ranges.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Akums_Drugs_Pharmaceuticals_Ltd_compare_with_the_supplied_Healthcare_peers\"><\/span><strong>How does Akums Drugs &amp; Pharmaceuticals Ltd. compare with the supplied Healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> By market capitalisation, Akums Drugs &amp; Pharmaceuticals Ltd. at Rs 10,483.23 crore is larger than every supplied peer, including Dishman Carbogen Amcis at Rs 3,060.41 crore and Hikal at Rs 2,862.43 crore in the comparison set.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Akums Drugs &#038; Pharmaceuticals Ltd. Share Price rises to Rs Rs 698.85. marking a 5.49% rise today. clearing the 5% threshold for Mid Cap stocks. Market cap<\/p>\n","protected":false},"author":29,"featured_media":190968,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-190969","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["190968"],"rank_math_title":["Akums Drugs &amp; Pharmaceuticals Ltd. Share Price: Mid Cap Gain"],"rank_math_description":["Akums Drugs &amp; Pharmaceuticals Ltd. Share Price rose 5.49% today. Check price action, market cap, sector benchmark and peer analysis in this stock update."],"rank_math_focus_keyword":["Akums Drugs & Pharmaceuticals Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Akums_Drugs_Pharmaceuticals_Ltd_AKUMS_Share_Price_Rises_549_Today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/190969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=190969"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/190969\/revisions"}],"predecessor-version":[{"id":190970,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/190969\/revisions\/190970"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/190968"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=190969"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=190969"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=190969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}